International Journal of Molecular Sciences· 2017Q1
Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
- 1,361citations
- Q1SCImago
- 2017year
Short summary
Mesenchymal stem cell (MSC) therapies may be more effective using their secreted factors (secretome) rather than the cells themselves, offering advantages in manufacturing, storage, and shelf life for regenerative medicine.
AI-generated from the title and abstract; the full text is not read.
Key points
- MSC therapy benefits are increasingly attributed to secreted factors (secretome) rather than cell engraftment.
- Secretome derivatives (conditioned media, exosomes) offer advantages in manufacturing, storage, and shelf life compared to cell therapies.
- Human uterine cervical stem cells (hUCESCs) are a promising source for secretome products due to less invasive isolation and high proliferation.
- Regulatory frameworks are needed to ensure the safety and efficacy of secretome-based products.
AI-generated from the title and abstract; the full text is not read.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
The authors' abstract, as published at the source. International Journal of Molecular Sciences, 2017 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Genetics (Medicine)
GeneticsMedicine